Bevacizumab Diminishes Experimental Autoimmune Encephalomyelitis by Inhibiting Spinal Cord Angiogenesis and Reducing Peripheral T-Cell Responses. Macmillan CJ, Furlong SJ, Doucette CD, Chen P-L, Hoskin DW, Easton AS J Neuropathol Exp Neurol. 2012 Oct 3. PMID: 23037326. Abstract CommentRecommendBookmarkWatch